FIMAN Joins Hands with Truking Technology to Empower the Smart Manufacturing Upgrade of Jingyue Plant

On May 16, Chen Xinwei, Director and General Manager of FIMAN, led the plant management team on a special visit to Truking Technology Limited, a leading enterprise in China’s pharmaceutical equipment industry. The delegation was warmly received by a group of senior executives, including Ouyang Wenlu, Co-President of Truking Group and Chairman of Truking Huatong; Zhong Yuanlong, Executive Dean of Truking Central Technology Research Institute; Lei Yu, Domestic Sales President and General Manager of Truking Boyuan; Liu Weihong, Senior Vice President and Board Secretary; and Dai Si, Senior Vice President and Deputy General Manager of Truking Huatong. The visitors were accompanied on on-site tours and participated in in-depth symposium exchanges.


As a pioneer in the active collagen industry, FIMAN has always prioritized basic collagen research and innovative application exploration. By establishing a university-enterprise joint laboratory with Fudan University, the company has built a complete transformation pathway for converting scientific research achievements from the "bookshelf" to the market "shelf", further consolidating the foundation of industry-university-research collaborative innovation.


This in-depth exchange with Truking Technology marks a crucial step for FIMAN to advance the upgrading of its full production system. According to Chen Xinwei, Director and General Manager of FIMAN, the Phase I and Phase II projects of the Changchun Jingyue Plant, with a total investment of nearly RMB 1 billion, serve as an intelligent R&D and production platform for active collagen that integrates scientific research, pilot-scale testing and large-scale standardized production. The strategic cooperation with Truking Technology represents a powerful alliance and complementary resource integration between upstream and downstream industrial chain enterprises. Moving forward, the two sides will deepen in-depth cooperation in equipment iteration, process optimization and technological upgrading, accelerate the commissioning and operation of the Phase II plant, achieve dual breakthroughs in production capacity and product quality, and further improve the closed-loop industrial system covering "basic research – laboratory incubation – large-scale intelligent manufacturing".


As a top-tier domestic pharmaceutical equipment enterprise, Truking Technology boasts profound technical accumulation in pharmaceutical equipment innovation and intelligent equipment research and development. The company owns 5,350 authorized patents, leads the formulation of multiple national and industry standards, and delivers products and services to over 180 countries and regions worldwide. Additionally, through the acquisition of Germany’s Romaco Group, it has mastered world-leading pharmaceutical manufacturing technologies. Committed to building a comprehensive "Truking Biomedical & Life Science Industrial Chain", Truking Technology can fully meet the intelligent upgrading demands of FIMAN’s Phase II plant and provide strong support for its smart manufacturing transformation and upgrading.
During the exchange session, the two teams jointly cherished the memory of the great leader Chairman Mao and consolidated their firm determination to adhere to independent innovation. As written in Chairman Mao’s Qinyuanchun·Snow, "If you want to see truly great men, look to this age." In the future, driven by the mission of manufacturing high-quality Chinese collagen products, FIMAN will continue to cooperate with leading industry partners such as Truking Technology. The company will persist in iterating and upgrading production and intelligent manufacturing systems, strive to fulfill its vision of "letting China lead the global collagen industry, with FIMAN as the benchmark of Chinese collagen", and empower the Chinese active collagen industry to move towards the high-end segment of the global value chain.